Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Plaque tissue refers to the biologically complex structure forming within the arterial wall during atherosclerosis. These plaques are composed of accumulated lipids, cholesterol crystals, cellular debris, fibrous extracellular matrix, smooth muscle cells, inflammatory cells (such as macrophages and T cells), and sometimes calcification. Progression of plaque tissue underlies many cardiovascular events by causing vessel narrowing, rupture, and thrombosis. Plaque tissue is highly heterogeneous, with subtypes defined by their inflammatory content, degree of calcification, lipid core size, and propensity for rupture or erosion, which determines their clinical risk. It is a pathological finding, not a specific molecule, receptor, or conventional drug target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plaque tissue.